Amphenol reported strong Q4 2022 results, with sales and adjusted diluted EPS exceeding the high end of guidance. Sales increased by 7% year-over-year, supported by robust growth in key markets. The company also announced the acquisition of CMR and an agreement to acquire assets of RFS, further expanding its growth opportunities.
Sales of $3.239 billion, up 7% in U.S. dollars and 8% organically compared to the fourth quarter of 2021
GAAP Diluted EPS of $0.82, up 14% compared to prior year
Adjusted Diluted EPS of $0.78, up 11% compared to prior year
Record Operating and Free Cash Flow of $705 million and $613 million
For the first quarter of 2023, Amphenol expects sales to be in the range of $2.840 billion to $2.900 billion, representing a 2% to 4% decline over the first quarter of 2022. Adjusted Diluted EPS is expected to be in the range of $0.65 to $0.67, representing a 3% decline to flat over the first quarter of 2022.
Visualization of income flow from segment revenue to net income